These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8721533)

  • 1. Allergic contact dermatitis from estradiol in a transdermal therapeutic system.
    Quirce S; Garde A; Baz G; Gonzalez P; Alonso Diaz de Durana MD
    Allergy; 1996 Jan; 51(1):62-3. PubMed ID: 8721533
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact dermatitis from estradiol in a transdermal therapeutic system.
    Panhans-Gross A; Gall H; Dziuk M; Peter RU
    Contact Dermatitis; 2000 Dec; 43(6):368-9. PubMed ID: 11140397
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic sensitization to 17-beta estradiol induced by transcutaneous administration].
    El Sayed F; Bayle-Lebey P; Marguery MC; Bazex J
    Ann Dermatol Venereol; 1996; 123(1):26-8. PubMed ID: 8734113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
    Ta V; Chin WK; White AA
    Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
    [No Abstract]   [Full Text] [Related]  

  • 6. Skin reactions to transdermal estrogen replacement therapy in a tropical climate.
    de Cetina TC; Reyes LP
    Int J Gynaecol Obstet; 1999 Jan; 64(1):71-2. PubMed ID: 10190675
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombotic thrombocytopenic purpura and 17 beta-estradiol transdermal skin patch.
    Liang R; Wong RW; Cheng IK
    Am J Hematol; 1996 Aug; 52(4):334-5. PubMed ID: 8701965
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hormone replacement therapy - less is often more].
    Schneider HP
    Zentralbl Gynakol; 2001 Sep; 123(9):546-7. PubMed ID: 11709750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergic contact dermatitis from ethanol in a transdermal estradiol patch.
    Pecquet C; Pradalier A; Dry J
    Contact Dermatitis; 1992 Oct; 27(4):275-6. PubMed ID: 1451512
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergic and systemic contact dermatitis from estradiol.
    Gonçalo M; Oliveira HS; Monteiro C; Clerins I; Figueiredo A
    Contact Dermatitis; 1999 Jan; 40(1):58-9. PubMed ID: 9928818
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transdermal estradiol and testosterone transfer in man: existence, models, and strategies for prevention.
    Busse KL; Maibach HI
    Skin Pharmacol Physiol; 2011; 24(2):57-66. PubMed ID: 21088452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menostar - a low-dose estrogen patch for osteoporosis.
    Med Lett Drugs Ther; 2004 Aug; 46(1190):69-70. PubMed ID: 15375352
    [No Abstract]   [Full Text] [Related]  

  • 16. [Systen--transdermal estradiol for substitution following surgical menopause].
    Rachev E; Karag'ozov I
    Akush Ginekol (Sofiia); 1995; 34(3):74-6. PubMed ID: 8743861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of the acceptability of a new estradiol Tx 11323 (A) gel and a transdermal matrix system].
    Gelas B; Thébault J; Roux I; Herbrecht F; Zartarian M
    Contracept Fertil Sex; 1997 Jun; 25(6):470-4. PubMed ID: 9280552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergic contact dermatitis due to transdermal buprenorphine.
    Pérez-Pérez L; Cabanillas M; Loureiro M; Fernández-Redondo V; Labandeira J; Toribio J
    Contact Dermatitis; 2008 May; 58(5):310-2. PubMed ID: 18416765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.